Prostate cancer (PCa) is one of the most common malignant tumors among men worldwide. Following androgen deprivation therapy ...

Investigators tested a new neoadjuvant immunotherapy to fight prostate cancer using a virus-mimicking drug to activate the ...

Prostate cancer patients with metastatic disease and low-volume primary tumors appear to have a poor prognosis, according to a recent analysis.

NCI-Led Study Shows Median PFS of 9.6 Months Results Presented at AACR Special Conference on Innovations in Prostate CancerPRINCETON, N.J., Jan.

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...

An article about the importance of PSA testing for early detection and treatment of prostate cancer ...

A surgeon at St. Clair Hospital in Mt. Lebanon recently performed the first HIFU procedure for prostate cancer at St. Clair using advanced new ultrasound technology. This makes St. Clair the first ...

This article summarizes metabolic reprogramming in prostate cancer (PCa). Early PCa relies more on glycolysis.

An Italian oncologic psychologist warns these patients: “A prostatectomy doesn’t cure anxiety.” Emotional distress can be so ...

Cancer and Alzheimer's are two of the most common chronic diseases associated with aging. For years, doctors have known about ...